Abstract B74: Can we repurpose anti-malarial drug quinacrine to treat ovarian cancer?
Debarshi Roy, Viji Shridhar(Mayo Clinic in Arizona), Ashwani Khurana(Mayo Clinic in Arizona), Eleftheria Kalogera(Mayo Clinic), Xuyang Wen(Mayo Clinic in Arizona), Susmita Mondal(Diamond Harbour Women's University)
Cited by 0
Related Papers
Multiple large bowel resections: Potential risk factor for anastomotic leak
|Gynecologic Oncology|2013|77
Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
|Oncogene|2021|62
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study
|Annals of Surgical Oncology|2017|54